Posted Sep. 27, 2012 at 2:37 p.m.

Premium Lock GSK, drug firms pay U.S. $6.6B in 2012 to settle fraud cases

Published: 2012-09-27 14:37:00
Updated: 2012-09-27 14:37:00

Healthcare reform Healthcare reform

Fines and penalties rose from $2.5 billion in 2011, aided by a record $3 billion settlement by Glaxo in July, Public Citizen said in a report Thursday. Common frauds include overcharging government programs such as Medicare and pushing doctors to prescribe drugs for unapproved uses....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders